Le Lézard
Classified in: Health, Science and technology
Subject: Product/Service

S2 Genomics Launches the Singulatortm 100 to Automate Tissue Preparation for Single-Cell and Single-Nucleus Analyses

S2 Genomics, a manufacturer of automated tissue sample preparation systems, announced today at the Advances in Genome Biology and Technology (AGBT)?2020 meeting the launch of the Singulatortm 100 System. The Singulator 100 System automates the processing of solid tissue samples into suspensions of single cells or nuclei with high yields and from small samples for a wide range of single-cell biology and genomic analyses.

Automated tissue preparation workflows can help ensure high-quality single-cell data and accelerate single-cell research for genomics, cell biology, and other ?omic applications. The Singulator 100 automates and standardizes the dissociation process of solid tissues, making it easy for researchers to reproducibly prepare suspensions of high-quality, highly viable cells or nuclei with minimal variability.

"Current methods of cell isolation are often manual or require a series of manual interventions, creating a significant workflow bottleneck and experimental inconsistencies for single cell researchers. The Singulator 100 overcomes these challenges by rapidly producing consistent, reproducible cell or nuclei suspensions from solid tissue samples without user interventions, reducing hours of hands-on processing to minutes," said Dr. Stevan Jovanovich, President and CEO of S2 Genomics.

The Singulator 100 will begin shipping in spring 2020 with kits available for single-cell and nuclei isolation.

About S2 Genomics, Inc.

S2 Genomics, founded in 2016, is a leading developer of laboratory automation solutions for processing solid tissues for life science applications. S2 Genomics' technology platforms integrate advanced fluidics, optics, and biochemistry to produce automated sample preparation solutions for the next generation sequencing (NGS) and cell biology markets, enabling discovery and innovation in life science research, healthcare, and agriculture. For more information, visit https://S2Genomics.com.

For Research Use Only. Not for use in diagnostic procedures.

S2 Genomics, the S2 Genomics logo, and Singulator are trademarks of S2 Genomics, Inc.

These press releases may also interest you

at 08:10
FirstWave Bio, Inc., a clinical-stage biotechnology company developing novel gut-targeted small molecules for inflammatory bowel disease and other serious conditions, today announced plans to initiate a Phase 2a/2b study in patients with COVID-19,...

at 08:10
Currency volatility was responsible for significant impacts on the revenues of U.S.-listed multinational corporations, costing them nearly $9 billion in Q4 2019, according to the new Kyriba Currency Impact Report (CIR), a comprehensive report which...

at 08:10
The COVID-19 pandemic has had a profound impact on people and organizations around the globe. Companies large and small have had to quickly adapt to new ways of working while addressing massive increases in customer inquiries and the need for help....

at 08:10
The Thryv Small Business Foundation announced today the first recipients of its Small Business COVID-19 Grant Program, a grant application program that awards immediate grants to struggling small businesses. First round recipients are small...

at 08:10
Keyavi Data, a data security technology company that embeds protection directly into data itself, today announced that the company's cybersecurity product is immediately available to enterprise customers worldwide. This new data protection...

at 08:10
WNS (Holdings) Limited , a leading provider of global Business Process Management (BPM) services, today announced it will release its fiscal 2020 fourth quarter and full year financial and operating results at approximately 6:00 a.m. Eastern on...

News published on 23 february 2020 at 12:30 and distributed by: